Treatment Strategy for Oligometastatic Gastric Cancer: Brief Considerations

Daniele Lavacchi¹, Elisa Giommoni¹, Fabio Cianchi^{2

3}, Lorenzo Antonuzzo^{4

5}

Affiliations

¹ Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
² Unit of Digestive Surgery, Careggi University Hospital, Florence, Italy.
³ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
⁴ Clinical Oncology Unit, Careggi University Hospital, Florence, Italy. lorenzo.antonuzzo@unifi.it.
⁵ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. lorenzo.antonuzzo@unifi.it.

Editorial

Daniele Lavacchi et al. J Gastrointest Cancer. 2023 Mar.

. 2023 Mar;54(1):6-8.

doi: 10.1007/s12029-021-00792-x. Epub 2022 Jan 30.

Daniele Lavacchi¹, Elisa Giommoni¹, Fabio Cianchi^{2

3}, Lorenzo Antonuzzo^{4

5}

¹ Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
² Unit of Digestive Surgery, Careggi University Hospital, Florence, Italy.
³ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
⁴ Clinical Oncology Unit, Careggi University Hospital, Florence, Italy. lorenzo.antonuzzo@unifi.it.
⁵ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. lorenzo.antonuzzo@unifi.it.

No abstract available

References

1. Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–48. https://doi.org/10.1016/S0140-6736(20)31288-5 (PMID: 32861308). - DOI - PubMed
1. Roviello G, Fancelli S, Gatta Michelet MR, et al. TAS-102 in gastric cancer: development and perspectives of a new biochemically modulated fluoropyrimidine drug combination. Crit Rev Oncol Hematol. 2020;152:102987. https://doi.org/10.1016/j.critrevonc.2020.102987 (Epub 2020 May 21 PMID: 32485527). - DOI - PubMed
1. Fanotto V, Cordio S, Pasquini G, et al. Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world. Gastric Cancer. 2017;20(5):825–33. https://doi.org/10.1007/s10120-016-0681-6 (Epub 2016 Dec 27 PMID: 28028664). - DOI - PubMed
1. Fornaro L, Spallanzani A, de Vita F, et al. Beyond the guidelines: the grey zones of the management of gastric cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers (Basel). 2021;13(6):1304. Published 2021 Mar 15. https://doi.org/10.3390/cancers13061304 .
1. Salati M, Valeri N, Spallanzani A, et al. Oligometastatic gastric cancer: an emerging clinical entity with distinct therapeutic implications. Eur J Surg Oncol. 2019;45(8):1479–82. https://doi.org/10.1016/j.ejso.2018.11.006 (Epub 2018 Nov 10 PMID: 30448343). - DOI - PubMed